Daniel Grosslight
Stock Analyst at Citigroup
(1.08)
# 3,854
Out of 5,091 analysts
111
Total ratings
32.84%
Success rate
-15.51%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $12 → $9.5 | $3.93 | +141.73% | 5 | Nov 21, 2025 | |
| HCAT Health Catalyst | Maintains: Neutral | $3.5 → $3.25 | $2.66 | +22.41% | 11 | Nov 11, 2025 | |
| CTEV Claritev | Maintains: Buy | $74 → $80 | $32.98 | +142.57% | 3 | Nov 10, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $165 → $190 | $198.88 | -4.47% | 10 | Oct 31, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $47 → $49 | $33.21 | +47.55% | 2 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $9.5 → $11 | $7.56 | +38.89% | 12 | Oct 21, 2025 | |
| MCK McKesson | Maintains: Buy | $820 → $860 | $797.93 | +7.78% | 8 | Sep 24, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $11 → $7 | $2.53 | +176.68% | 7 | Aug 12, 2025 | |
| AGL agilon health | Downgrades: Neutral | $3 → $1 | $0.69 | +44.07% | 6 | Aug 6, 2025 | |
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $39.12 | -23.31% | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $6.25 | $2.72 | +129.78% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $20.12 | +73.96% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $23.63 | +5.80% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $3.67 | +172.48% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $13.30 | -39.85% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $1.35 | -7.41% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.13 | +11.82% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.39 | +38.45% | 1 | Dec 11, 2019 |
Evolent Health
Nov 21, 2025
Maintains: Buy
Price Target: $12 → $9.5
Current: $3.93
Upside: +141.73%
Health Catalyst
Nov 11, 2025
Maintains: Neutral
Price Target: $3.5 → $3.25
Current: $2.66
Upside: +22.41%
Claritev
Nov 10, 2025
Maintains: Buy
Price Target: $74 → $80
Current: $32.98
Upside: +142.57%
Cardinal Health
Oct 31, 2025
Maintains: Neutral
Price Target: $165 → $190
Current: $198.88
Upside: -4.47%
Waystar Holding
Oct 31, 2025
Maintains: Buy
Price Target: $47 → $49
Current: $33.21
Upside: +47.55%
Teladoc Health
Oct 21, 2025
Maintains: Neutral
Price Target: $9.5 → $11
Current: $7.56
Upside: +38.89%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $820 → $860
Current: $797.93
Upside: +7.78%
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $2.53
Upside: +176.68%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $0.69
Upside: +44.07%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $39.12
Upside: -23.31%
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $2.72
Upside: +129.78%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $20.12
Upside: +73.96%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $23.63
Upside: +5.80%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $3.67
Upside: +172.48%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $13.30
Upside: -39.85%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $1.35
Upside: -7.41%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.13
Upside: +11.82%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.39
Upside: +38.45%